Our Business
Almoosa Health Company, deemed a private healthcare leader, started in 1996 as Almoosa General Hospital, the first private hospital in Al Ahsa. Today, it is an integrated healthcare ecosystem with 730 beds in Saudi Arabia's Eastern Province. The Company provides integrated healthcare services that include primary, acute and rehabilitative care along with ancillary services such as pharmaceutical, home healthcare and telemedicine.
Our Vision
To be a trusted world class health system that promotes wellness and heals illness.
Our Mission
We serve with passion across the care continuum, lead with innovation, and promote community transformation.
Our Facilities
Al Moosa Specialist Hospital, a 430-bed facility, is internationally accredited and renowned for its Centers of Excellence across various medical specialties. It is home to Al Ahsa's first comprehensive cancer center, providing advanced oncology care.
Al Moosa Rehabilitation Hospital, a 300-bed facility launched in late 2023, has partnered with the renowned Shirley Ryan AbilityLab to provide specialized centers and services.
Share Performance
| Share data | 23/04/2025 | ||
| Currency | SAR | Volume | 37,553 |
| Previous Close | 164.20 | Number of Shares (mn) | 44.30 |
| Change (%) | 0.00 | Market Cap (mn) | 7,274.65 |
Almoosa Health in Numbers
Consolidated Statement of Financial Position |
FY 2022 |
FY 2023 |
FY 2024 |
| Non-current assets | 1,427.4 |
1,753.7 |
1,928.4 |
| Current assets | 397.8 |
548.1 |
625.0 |
| Total assets | 1,825.2 |
2,301.8 |
2,553.4 |
| Total equity | 648.1 |
656.0 |
717.7 |
| Non-current liabilities | 775.5 |
1,158.1 |
1,272.9 |
| Current liabilities | 401.5 |
487.7 |
562.8 |
| Total liabilities | 1,177.0 |
1,645.8 |
1,835.7 |
Consolidated Income Statement |
FY 2022 |
FY 2023 |
FY 2024 |
| Revenue | 816.0 |
979.0 |
1,202.3 |
| Gross profit | 239.0 |
307.0 |
371.7 |
| Operating profit | 70.9 |
128.2 |
187.0 |
| Net Profit before zakat | 55.6 |
101.8 |
102.9 |
| Net Profit for the year | 51.0 |
98.1 |
94.4 |
Consolidated Statement of Cash Flows |
FY 2022 |
FY 2023 |
FY 2024 |
| Net cash from operating activities | -9.9 |
40.1 |
183.7 |
| Net cash used in investing activities | -316.7 |
-454.4 |
-262.2 |
| Net cash used in financing activities | 283.8 |
414.9 |
100.9 |
| Cash and cash equivalents at the end of the period | 15.2 |
15.8 |
38.2 |
Revenue by Segment |
FY 2022 |
FY 2023 |
FY 2024 |
| Medical services | 661.4 |
735.4 |
825.6 |
| Pharmaceuticals | 154.6 |
186.7 |
258.2 |
| Rehabilitation | Launched in 2023 |
56.8 |
118.5 |
